LIDOCAINE HYDROCHLORIDE INJECTION USP
FORMATIVE PHARMA INC.
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of LIDOCAINE HYDROCHLORIDE INJECTION USP in Canada?
A shortage of LIDOCAINE HYDROCHLORIDE INJECTION USP 20MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated October 23, 2026), but it has not started yet.
Why is LIDOCAINE HYDROCHLORIDE INJECTION USP not available?
The reason the manufacturer reported: Requirements related to complying with good manufacturing practices.
When will LIDOCAINE HYDROCHLORIDE INJECTION USP be available again?
No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
XYLOCAINE 2%
ASPEN PHARMACARE CANADA INC.
Other Products
XYLOCAINE JELLY 2%
ASPEN PHARMACARE CANADA INC.
XYLOCAINE 1%
ASPEN PHARMACARE CANADA INC.
XYLOCARD
ASPEN PHARMACARE CANADA INC.
LIDODAN VISCOUS 2%
ODAN LABORATORIESLTD
What this means
Does this mean my pharmacy is already out of stock?
No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.
What should I do?
This product is usually given in a hospital or clinic, where the pharmacy team manages supply. If you're scheduled to receive it, ask your care team.
⚠ Possible Recall or Safety Alert
Health Canada has issued a recall or safety alert matching this product. This match is based on product name similarity and may not be exact — confirm against your specific lot number before taking action.
Lidocaine Hydrochloride and Epinephrine Injection USP
Lidocaine Hydrochloride and Epinephrine Injection USP: Affected lot may contain particles.
Highest health risk
Possible match — not confirmed
0.4% Lidocaine Hydrochloride & 5% Dextrose Injection
0.4% Lidocaine Hydrochloride & 5% Dextrose Injection: Solution bags may be leaking in affected lots. (Updated with new lot numbers)
Highest health risk
Possible match — not confirmed
DIN
02547856
Strength
20MG
Dosage Form
SOLUTION
Route
EPIDURAL BLOCK/INFILTRATION
Compare with another product →
Shortage Timeline
Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.
Shortage History
Other Products from FORMATIVE PHARMA INC.
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
250MG · DIN 02539586
7.5MG · DIN 02536714
45MG · DIN 02553783
60MG · DIN 02553791
250MG · DIN 02536293
500MG · DIN 02537168
10MG · DIN 02534827